Corcept Therapeutics Incorporated (LON:0I3Q)

Corcept Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 28, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,591	4,217	2,629	1,815	1,549	2,226
Market Cap Growth	60.44%	60.44%	44.86%	17.14%	-30.41%	113.20%
Enterprise Value	5,146	3,785	2,303	1,483	1,184	1,903
Last Close Price	53.38	40.34	25.73	16.74	14.79	19.59
PE Ratio	50.09	37.78	31.74	21.59	18.64	28.67
PS Ratio	10.37	7.82	6.94	5.44	5.73	8.59
PB Ratio	10.30	7.77	6.61	4.36	5.58	5.81
P/TBV Ratio	10.30	7.77	6.61	4.36	5.58	5.81
P/FCF Ratio	35.73	26.95	26.38	18.23	12.53	20.16
P/OCF Ratio	35.34	26.66	26.36	18.17	12.49	20.00
EV/Sales Ratio	10.21	7.02	6.08	4.45	4.38	7.34
EV/EBITDA Ratio	48.95	34.40	27.08	15.69	12.73	20.18
EV/EBIT Ratio	50.30	34.60	27.34	15.87	12.88	20.26
EV/FCF Ratio	32.88	24.19	23.12	14.90	9.58	17.24
Debt / Equity Ratio	0.01	0.01	0	0.00	0.00	0.01
Debt / EBITDA Ratio	0.05	0.05	0.00	0.01	0.00	0.02
Debt / FCF Ratio	0.04	0.04	0.00	0.01	0.00	0.02
Asset Turnover	0.92	0.92	0.80	0.80	0.74	0.72
Inventory Turnover	1.08	1.08	0.94	0.97	1.07	1.08
Quick Ratio	3.11	3.11	4.05	6.60	5.31	9.86
Current Ratio	3.35	3.35	4.39	6.89	5.61	10.07
Return on Equity (ROE)	23.81%	23.81%	21.05%	23.11%	25.03%	23.70%
Return on Assets (ROA)	11.71%	11.71%	11.13%	13.98%	15.63%	16.29%
Return on Capital (ROIC)	14.34%	14.34%	13.28%	16.01%	17.25%	17.79%
Return on Capital Employed (ROCE)	19.60%	19.60%	20.80%	22.00%	33.10%	24.50%
Earnings Yield	2.00%	2.67%	3.17%	4.64%	5.36%	3.49%
FCF Yield	2.80%	3.71%	3.79%	5.48%	7.98%	4.96%
Buyback Yield / Dilution	-1.55%	-1.55%	3.64%	7.94%	-1.42%	-1.33%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.